Process for extracting human coagulation factor VIII from plasma

A human blood coagulation factor and plasma technology, applied in the direction of blood coagulation/fibrinolysis factor, VII factor, peptide preparation method, etc., can solve the problems of time-consuming, cumbersome steps, poor stability, etc.

Active Publication Date: 2014-06-18
新疆德源生物工程有限公司
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Up to now, there have been many methods for extracting and purifying factor VIII from blood at home and abroad. Although the existing multi-step ion exchange chromatography has a high purification rate, the steps are cumbersome and require a lot of time; in recent years, monoclonal antibody technology The development of immunoaffinity chromatography has been a...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for extracting human coagulation factor VIII from plasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1: Different separation methods compare the final product parameters of human blood coagulation factor VIII:

[0019]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an economic and simple method for improving the separation efficiency, activity, specific activity and recovery rate of coagulation factor VIII. The method comprises washing cryoprecipitate twice with sodium heparin firstly, then carrying out ion exchange chromatography and eluting with an eluent to obtain higher-purity coagulation factor VIII. Compared with traditional methods, the method has the advantages of simple process and low cost; the separation efficiency, activity, specific activity and recovery rate of the coagulation factor VIII are also improved.

Description

technical field [0001] The invention relates to a preparation process of human blood coagulation factor VIII, which belongs to the field of biopharmaceuticals. Background technique [0002] Blood coagulation factor Ⅷ is the only specific drug for the treatment of hemophilia A, which has great clinical application value. Due to the defect of blood coagulation mechanism, the patient often bleeds incessantly when encountering trauma, so a sufficient amount of blood coagulation factor Ⅷ preparation needs to be injected, plus blood coagulation The half-life of factor VIII in the human body is only 8 to 12 hours. Although the effect is remarkable, it cannot last long. Once you get sick, you will need this drug for life. Although the number of such people is small, the demand is high, so the supply exceeds demand in the world. [0003] Out of safety considerations, my country has no plans to lift the ban on blood imports. The Chinese market is entirely produced by domestic manufac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/755C07K1/14
CPCC07K14/755
Inventor 吕献忠苏峰
Owner 新疆德源生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products